Please Wait

Applying Filters...

J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

Stock Recap
#PipelineProspector

DSSTox_CID_29375

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 4 USDMF, 6 CEP/COS, 2 JDMF, 2 EU WC, 2 KDMF, 12 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

111 FDF Dossiers, 31 FDA Orange Book, 48 Europe, 31 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.25%;0.0091MG/ML, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML), INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML), INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

4 Actylis

4 Actylis

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 9 News #PharmaBuzz

GLOBAL SALES INFORMATION

36 Regulatory FDF Prices

36 Regulatory FDF Prices

MARKET PLACE

28 APIs, 3 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 2 JP, 1 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
28/06/2025	Syn-Tech Chem. & Pharm	Taiwan	Syn-Tech Chem. & Pharm. Co. , Ltd.	303MF10034	Epinephrine Hydrogen tartrate	2021-02-16	2021-02-16	No. 168 Kai-Yuan Rd. , Hsin-Ying Tainan City, 73055. Taiwan
28/06/2025	Viyash Life Sciences	India	Viyash Life Sciences Private Limited	307MF10050	Epinephrine Tartrate	2025-04-02	2025-04-02	Plot No. 290, Srivalli's Corporate, Road No. 6, Kakatiya Hills, Madhapur, Hyderabad-500 081, Telangana, India

Contact us
to update this info

DSSTox_CID_29375

DSSTox_CID_29375

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers

4 USDMF

6 CEP/COS

2 JDMF

2 EU WC

2 KDMF

12 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

111 FDF Dossiers

31 FDA Orange Book

48 Europe

31 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 0.25%

INJECTABLE;INJECTION - 0.25%;0.0091MG/ML

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - 0.75%

INJECTABLE;INJECTION - 0.75%;0.0091MG/ML

INJECTABLE;INJECTION - 0.25%

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - 0.75%

INJECTABLE;INJECTION - 0.75%;0.0091MG/ML

INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML)

INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML)

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

4 Actylis

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

36 Regulatory FDF Prices

MARKET PLACE

28 APIs

3 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM

2 JP

1 Others

Filters